Navigation Links
Informed Medical Communications Highlights Opportunity in Revised PhRMA Code
Date:8/11/2008

EDISON, N.J., Aug. 11 /PRNewswire/ -- Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, issued its position today on recent revisions to the PhRMA Code. "IMC remains fully committed to compliance with the PhRMA Code," noted Dr. Jaime Nguyen, Medical Director/Compliance Officer for IMC. "Though the guidelines have changed, we have continually monitored the compliance trends so that our services can remain a valuable resource for our clients in reaching their customers."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080512/NYM105LOGO )

With the ongoing restrictions on sales representative involvement, IMC (including The Peer Group and RxDialogue) has always proactively evolved its services to maintain the highest level of compliance rigor, enabling their clients a safe option for effectively meeting the needs of their brands. "IMC's medical communications will continue to be one of the few available tactics offering high-impact results for brand teams because its informational presentations and interactive discussions improve patient care and increase exposure to disease states and therapeutic choices," noted Kathleen Bresette, President of The Peer Group. Additionally, IMC's unique use of compliance-trained clinical Moderators ensures a viable, valuable method for supporting biopharmaceutical brands.

Steve Budd, CEO of IMC commented, "Because of this changing regulatory environment, IMC continually scrutinizes the compliance of its services, imbuing in our clients a confidence that IMC medical communications services like our Moderator Advantage Programs (MAPs) and teleconferences will remain an ideal tactic for discussing promotional on-label brand messages with healthcare professionals."

About Informed Medical Communications

Informed Medical Communications (http://www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting general and specialty peer-to-peer medical programs, respectively. Additionally, IMC's major businesses are enhanced by MRxHealth, the market research and consulting infrastructure that supports IMC's ongoing development and effectiveness of non-traditional marketing programs for biopharmaceutical clients, and Dialogue Training, a communications training service for elite skill development in three areas: (1) leadership, (2) sales, and (3) training/facilitation. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.


'/>"/>
SOURCE Informed Medical Communications
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pharmacy Students Taught Improved Medication Adherence and Holistic Health Services Through Program Incorporating InforMedixs Med-eXpert(TM) System
2. Informed Medical Communications Adopts Newly Enhanced Compliance Policy
3. Informed Medical Communications Appoints New Chief Financial Officer
4. Informed Medical Communications Hires New Vice President of Marketing
5. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
6. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors
7. ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies
8. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
9. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
11. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO); $3.57 Price Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2018)... (PRWEB) , ... July 27, ... ... and Renewable Products Advocacy Group (BRAG®) and representatives of the Biotechnology Innovation ... the two groups’ recently-issued white paper, “Proposal for a Toxic Substances Control ...
(Date:7/25/2018)... ... July 25, 2018 , ... Dimitrius Anagnos, an evidence-based healer, ... inflammation and autoimmune disorders. , The preclinical research assessed biomarkers for systemic ... reported:, Over 70% decrease in Interleukin (IL-1ß) expression ...
(Date:7/25/2018)... , ... July 25, 2018 , ... ... for managing clinical trial patient and supplies data through its flagship IXRS® ... on IRT: Best Practices.” , This podcast features both Almac thought leaders and ...
(Date:7/24/2018)... ... ... R3 Stem Cell is now offering regenerative therapies for COPD lung disease ... Certified providers, with outcomes significantly improving patient quality of life. , Traditional therapies for ... help repair and regenerate damaged lung tissues. Stem cell therapy for COPD ...
Breaking Biology Technology:
(Date:8/7/2018)... ... August 07, 2018 , ... ... and biotherapeutics development, announces a new publication titled, “Synthetic Molecules for Disruption ... Chemistry. The paper prominently features use of Agile R100, described as a “ ...
(Date:8/2/2018)... ... August 02, 2018 , ... The American College of Lifestyle ... to its Lifestyle Medicine Corporate Roundtable, a group of individuals and organizations whose ... sustainable world. , Boston Heart is transforming the treatment of cardiovascular disease ...
(Date:8/1/2018)... ... August 01, 2018 , ... RURO, Inc., ... Limfinity® version 7.1. Limfinity® is the software framework that all of RURO’s products ... for both current users and the future of RURO’s laboratory software portfolio. , ...
Breaking Biology News(10 mins):